Deuterium Magnetic Resonance Imaging (dMRI) for In Vivo Visualization of Rapidly-Dividing Cells

The National Cancer Institute seeks licensees for a method for in vivo visualization of rapidly-dividing cells and dynamic measurement of cellular kinetics using Deuterium Magnetic Resonance Imaging (dMRI).

Potential Commercial Applications: Competitive Advantages:
  • Non-invasive diagnostic, non-radioactive labeling-imaging approach for many cell types, including neoplastic cells.
  • Less invasive alternative to current diagnostic procedures, such as biopsies: decreases patient discomfort.
  • Faster detection method can improve patient responses to treatment and survival rates

Development Stage:
Discovery (Lead Identification)


Nataliya Buxbaum (NCI)  ➽ more inventions...

Intellectual Property:
US Application No. 62/414,554
US Application No. PCT/US2017/058856
Application No. PCT/US2017/058856

Collaboration Opportunity:

Licensing only

Licensing Contact:
Phone: 240-276-5515

OTT Reference No: E-188-2016
Updated: Feb 2, 2018